Aller au contenu

Interactions médicamenteuses

Bendamustine + Brexucabtagene autoleucel

Gravité: Majeure

Bendamustine and Brexucabtagene autoleucel: major interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Bendamustine is lymphotoxic and myelosuppressive. Recent exposure before apheresis can reduce T-cell yield and quality, and use after infusion may harm CAR T cells and raise infection risk.

Ce que signifie cette interaction, en termes simples

Bendamustine and Brexucabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bendamustine belongs to Oncology; Brexucabtagene autoleucel belongs to Oncology.

Niveau de preuve: Low

Pourquoi elle survient

Additive immunosuppression and lymphodepletion with potential cytotoxicity to T cells.

Conduite à tenir

Observe the recommended washout interval between bendamustine and apheresis, and avoid it after infusion except in a planned lymphodepletion protocol. Monitor blood counts and infections.

Questions à poser à votre pharmacien

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Bendamustine et Brexucabtagene autoleucel, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Bendamustine with Brexucabtagene autoleucel?

MediHelp rates the interaction as major. Bendamustine and Brexucabtagene autoleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Bendamustine is lymphotoxic and myelosuppressive. Recent exposure before apheresis can reduce T-cell yield and quality, and use after infusion may harm CAR T cells and raise infection risk.

How serious is the interaction between Bendamustine and Brexucabtagene autoleucel?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Observe the recommended washout interval between bendamustine and apheresis, and avoid it after infusion except in a planned lymphodepletion protocol. Monitor blood counts and infections.

What other medicines interact with Bendamustine?

MediHelp also lists interactions of Bendamustine with, for example, Axicabtagene ciloleucel, Chlorambucil, Ciltacabtagene autoleucel. The full list is on the Bendamustine page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter